OREX Related Hot FDA News
-
FDA Panel Votes 17-6 Obesity Drugmakers Should Study Heart Risks; Watch Orexigen (OREX, VIVUS (VVUS), Arena (ARNA)
-
Orexigen (OREX) Reports that DMEP Requests More Info on Contrave that "Would Generate Significantly More Information Than is Necessary or Feasible"
-
Orexigen (OREX) Shares Plummet as FDA Shows Concern for Long-Term Safety Profile of Contrave
-
Orexigen (OREX) says FDA issues CRL to NDA for Contrave
-
Orexigen Therapeutics (OREX) Skyrockets 150% On FDA Panel Backing of Contrave
-
Orexigen (OREX) wins panel's recommendation for contrave in a 13-7 vote
-
FDA Panel Votes 11-8 to Recommend Heart Study After Approval of Orexigen's (OREX) Contrave
-
Orexigen Therapeutics (OREX) Halted As Panel Reviews Contrave
-
Orexigen Therapeutics (OREX) Sees Downside After FDA Briefing Documents Posted
Back to OREX Stock Lookup
